Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases
M. Ryan Corces(Gladstone Institutes), Thomas J. Montine(Stanford University), Stephen B. Montgomery(Stanford University), Maxwell R. Mumbach(Stanford University), Kathleen S. Montine(Stanford University), Shadi Shams(Stanford University), Jeffrey M. Granja(Enable Biosciences (United States)), Howard Y. Chang(Stanford University), Tiffany Eulalio(Stanford Medicine), Bryan H. Louie(University of California San Diego), Boxiang Liu(Agency for Science, Technology and Research), Anna Shcherbina, William J. Greenleaf(Stanford University), Michael J. Gloudemans, S. Tansu Bagdatli(Stanford University), Anshul Kundaje(Stanford University), Soumya Kundu(Stanford University), Laure Frésard(Vanderbilt University Medical Center)
Cited by 389
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k